PDB57 LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE 1 DIABETES PATIENTS TREATED WITH A BASAL-BOLUS REGIMEN IN GERMANY
Abstract
Authors
T Wiesner PK SchAdlich FW Dippel K Koltermann EG Hagenmeyer